Δ133p53α enhances metabolic and cellular fitness of TCR-engineered T cells and promotes superior antitumor immunity.
Legscha KJ, Antunes Ferreira E, Chamoun A, Lang A, Awwad MHS, Ton GNHQ, Galetzka D, Guezguez B, Hundemer M, Bourdon JC, Munder M, Theobald M, Echchannaoui H.
Legscha KJ, et al. Among authors: chamoun a.
J Immunother Cancer. 2021 Jun;9(6):e001846. doi: 10.1136/jitc-2020-001846.
J Immunother Cancer. 2021.
PMID: 34112738
Free PMC article.